Trial Profile
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Cataplexy; Narcolepsy
- Focus Pharmacodynamics
- 06 Mar 2017 Status changed from recruiting to completed.
- 15 Mar 2014 New trial record